States settle with drug company: $68.5 million judgment
Thirty-eight state attorneys general have settled with the maker of an anti-psychotic drug, resolving charges of misleading marketing for the medication....
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch